United States · FDA National Drug Code directory
Lincomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-374_5834c892-22e9-1e32-e063-6294a90a0ae5
- Product NDC
- 42571-374
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lincomycin
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220201
- Source listing expiry
- 20271231
Source-listed ingredients
- LINCOMYCIN HYDROCHLORIDE — 300 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (42571-374-75) / 2 mL in 1 VIAL · 42571-374-75
- 1 VIAL in 1 CARTON (42571-374-88) / 10 mL in 1 VIAL · 42571-374-88
- 10 VIAL in 1 CARTON (42571-374-89) / 10 mL in 1 VIAL · 42571-374-89
- 10 VIAL in 1 CARTON (42571-374-91) / 2 mL in 1 VIAL · 42571-374-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →